Estimation of parameters for the elimination of an orally administered test substance with unknown absorption

Journal of Pharmacokinetics and Pharmacodynamics - Tập 40 - Trang 177-187 - 2013
Josef A. Vogt1, Christian Denzer2
1Sektion Anästhesiologische Pathophysiologie und Verfahrensentwicklung, Universitätklinikum für Anästhesiologie, Ulm, Germany
2Pediatric Endocrinology, Diabetes and Obesity Unit, Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany

Tóm tắt

Assessment of the elimination of an oral test dose based on plasma concentration values requires correction for the effect of gastric release and absorption. Irregular uptake processes should be described ‘model independently’, which requires estimation of a large number of absorption parameters. To limit the associated computational effort a new approach is developed with a reduced number of unknown parameters. A marginalized and regularized absorption approach (MRA) is defined, which uses for the uptake just one parameter to control rigidity of the uptake curve. For validation, elimination and absorption were reproduced using published IVIVC data and a synthetic data set for comparison with approaches using a ‘model-free’—staircase function or mechanistic models to describe absorption. MRA performed almost as accurate as well specified mechanistic models, which gave the best reproduction. MRA demonstrated a 50fold increase in computational efficiency compared to other approaches. The absorption estimated for the IVIVC study demonstrated an in vivo–in vitro correlation comparable to published values. The newly developed MRA approach can be used to efficiently and accurately estimate elimination and absorption with a restricted number of adaptive parameters and with automatic adjustment of the complexity of the uptake.

Tài liệu tham khảo

Csajka C, Drover D, Verotta D (2005) The use of a sum of inverse Gaussian functions to describe the absorption profile of drugs exhibiting complex absorption. Pharm Res. 22: 1227–1235 Zhou H (2003) Pharmacokinetic strategies in deciphering atypical drug absorption profiles. J Clin Pharmacol. 43(3):211–227 Lipka E, Lee ID, Langguth P, Spahn-Langguth H, Mutschler E, Amidon G (1995) Celiprolol double-peak occurrence and gastric motility: nonlinear mixed effects modeling of bioavailability data obtained in dogs. J Pharmacokinet Biopharm. 23:267–286 Gerlowski LE, Jain RK (1983) Physiologically based pharmacokinetic modeling: principles and applications. J Pharm Sci. 72(10):1103–1127 Blakey G, Nestorov I, Arundel P, Aarons L, Rowland M (1997) Quantitative structure-pharmacokinetics relationships: I. Development of a whole-body physiologically based model to characterize changes in pharmacokinetics across a homologous series of barbiturates in the rat. J Pharmacokinet Biopharm. 25:277–312 Yu LX, Amidon GL (1999) A compartmental absorption and transit model for estimating oral drug absorption. Int J pharm. 186(2):119–125 Di Muria M, Lamberti G, Titomanlio G (2010) Physiologically based pharmacokinetics: a simple, all purpose model. Ind Eng Chem Res. 49(6):2969–2978 Savic RM, Jonker DM, Kerbusch T, Karlsson MO (2007) Implementation of a transit compartment model for describing drug absorption in pharmacokinetic studies. J Pharmacokinet Pharmacodyn. 34(5):711–726 Weiss M (1984) A note on the rôle of generalized inverse Gaussian distributions of circulatory transit times in pharmacokinetics. J Math Biol. 20:95–102 Wikipedia (2011) Inverse Gaussian distribution—Wikipedia, The free encyclopedia http://en.wikipedia.org/wiki/InverseGaussiandistribution. Higaki K, Yamashita S, Amidon GL (2001) Time-dependent oral absorption models. J Pharmacokinet Pharmacodyn. 28(2):109–128 Karlsson M, Beal S, Sheiner L (1995) Three new residual error models for population PK/PD analyses. J Pharmacokinet Pharmacodyn. 23(6):651–672 Iga K, Ogawa Y, Yashiki T, Shimamoto T (1986) Estimation of drug absorption rates using a deconvolution method with nonequal sampling times. J Pharmacokinet Pharmacodyn. 14(2):213–225 Lindberg-Freijs A, Karlsson MO (1994) Dose dependent absorption and linear disposition of cyclosporin A in rat. Biopharm Drug Disposit. 15(1):75–86 Fattinger K, Verotta D (1995) A nonparametric subject-specific population method for deconvolution: I. Description, internal validation, and real data examples. J Pharmacokinet Pharmacodyn. 23:581–610 Wikipedia (2011) Splines (mathematics)—Wikipedia, The free encyclopedia http://en.wikipedia.org/wiki/Spline_mathematics. Mason JC, Handscomb DC (2003) Chebyshev polynomials. Chapman and Hall/CRC press, Boca Raton Park K, Verotta D, Blaschke TF, Sheiner LB (1997) A semiparametric method for describing noisy population pharmacokinetic data. J Pharmacokinet Pharmacodyn. 25(5):615–642 Hastie T, Tibshirani R, Friedman JH (2008) The elements of statistical learning 2nd edn. Springer, New york Bishop CM (2007) Pattern recognition and machine learning (information science and statistics), 1st edn. Springer, New york Dormand JR, Prince PJ (1980) A family of embedded Runge-Kutta formulae. J Comput Appl Math. 6(1):19–26 Powell MJD (2009) The BOBYQA algorithm for bound constrained optimization without derivatives. Centre for mathematical sciences, University of Cambridge, UK. Report DAMTP 2009/NA06. http://www.damtp.cam.ac.uk/user/na/NA_papers/NA2009_06.pdf Dutta S, Qiu Y, Samara E, Cao G, Granneman GR (2005) Once-a-day extended-release dosage form of divalproex sodium III: Development and validation of a level A in vitro–in vivo correlation (IVIVC). J Pharm Sci. 94(9):1949–1956 DiMuria M, Lamberti G, Titomanlio G (2009) Modeling the pharmacokinetics of extended release pharmaceutical systems. Heat Mass Transfer. 45(5):579–589 Press W, Teukolsky S, Vetterling W, Flannery B (2002) Numerical recipes in C++: the art of scientific computing. Cambridge University Press, Cambridge